Record Information
Version1.0
Creation Date2019-07-14 16:37:47 UTC
Last Updated2019-10-01 21:41:49 UTC
CypComp IDCC02295
Compound Information
NameReduced dolasetron
Structure ImageMlwgaevswjxoqj xyloafbbsa n
InChIKeyMLWGAEVSWJXOQJ-XYLOAFBBSA-N
PubChem IDNot Available
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <1,H;Hydroxylation;R1>
  • <5,H;Hydroxylation;R2>
  • <6,H;Hydroxylation;R3>
  • Not Available
  • <6,H;Hydroxylation;R1>
  • <16,N;N-Oxidation;R2>
References
  1. Sanwald P, David M, Dow J: Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists. Drug Metab Dispos. 1996 May;24(5):602-9. [PubMed:8723743 ]
Download FileCC02295.sdf